Lataa...

Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy

Recently, immunotherapeutic drugs, including PD-1 inhibitors (nivolumab, pembrolizumab), PD-L1 inhibitors (atezolizumab, avelumab), and CTLA4 inhibitors (ipiliumumab), have emerged as important additions to the armamentarium against certain malignancies and have been incorporated into therapeutic pr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Case Rep Oncol
Päätekijät: Palla, Amruth R., Kennedy, Devin, Mosharraf, Hossain, Doll, Donald
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2016
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5126613/
https://ncbi.nlm.nih.gov/pubmed/27920704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000452296
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!